151 related articles for article (PubMed ID: 1966729)
1. The role of serotonin in thrombogenesis.
De Clerck F
Clin Physiol Biochem; 1990; 8 Suppl 3():40-9. PubMed ID: 1966729
[TBL] [Abstract][Full Text] [Related]
2. Amplification mechanisms in platelet activation and arterial thrombosis.
De Clerck FF; Janssen PA
J Hypertens Suppl; 1990 Dec; 8(7):S87-93. PubMed ID: 2128890
[TBL] [Abstract][Full Text] [Related]
3. Insights into the role of thromboxane A2 and serotonin in the pathogenesis of unstable angina.
Machado AP; Saavedra JA; Ribeiro C
Rev Port Cardiol; 1994 Dec; 13(12):935-46, 893. PubMed ID: 7873224
[TBL] [Abstract][Full Text] [Related]
4. Effect of thromboxane and serotonin receptor antagonists on intracoronary platelet deposition in dogs with experimentally stenosed coronary arteries.
Golino P; Buja LM; Ashton JH; Kulkarni P; Taylor A; Willerson JT
Circulation; 1988 Sep; 78(3):701-11. PubMed ID: 3409505
[TBL] [Abstract][Full Text] [Related]
5. Functional expression of the amplification reaction between serotonin and epinephrine on platelets.
De Clerck F; Xhonneux B; de Chaffoy de Courcelles D
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S1-5. PubMed ID: 2459505
[TBL] [Abstract][Full Text] [Related]
6. Role of 5-hydroxytryptamine in platelet thrombus formation and mechanisms of inhibition of thrombus formation by 5-hydroxytryptamine2A antagonists in rabbits.
Takano S
Arch Int Pharmacodyn Ther; 1995; 330(3):297-308. PubMed ID: 8836449
[TBL] [Abstract][Full Text] [Related]
7. Role of serotonin, histamine, and thromboxane A2 in platelet-induced contractions of coronary arteries and aortae from rabbits.
Awano K; Yokoyama M; Fukuzaki H
J Cardiovasc Pharmacol; 1989 May; 13(5):781-92. PubMed ID: 2472528
[TBL] [Abstract][Full Text] [Related]
8. Implications of thrombosis and vasospasm in peripheral vascular disease.
Hollenberg NK
J Cardiovasc Pharmacol; 1991; 17 Suppl 5():S21-8. PubMed ID: 1717769
[TBL] [Abstract][Full Text] [Related]
9. 5-Hydroxytryptamine and thromboxane A2 in ischaemic heart disease.
De Clerck F; Janssen PA
Blood Coagul Fibrinolysis; 1990 Jun; 1(2):201-9. PubMed ID: 2130932
[TBL] [Abstract][Full Text] [Related]
10. Contractions of isolated canine coronary arteries resistant to S2-serotonergic blockade.
Cohen RA
J Pharmacol Exp Ther; 1986 May; 237(2):548-52. PubMed ID: 2939235
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a role of serotonin in initiation of coronary arterial thrombosis in dog and man.
Noble MI; Drake-Holland AJ
Clin Physiol Biochem; 1990; 8 Suppl 3():50-5. PubMed ID: 1966730
[TBL] [Abstract][Full Text] [Related]
12. Effects of serotonin on platelets and blood vessels.
De Clerck F
J Cardiovasc Pharmacol; 1991; 17 Suppl 5():S1-5. PubMed ID: 1717767
[TBL] [Abstract][Full Text] [Related]
13. Antithrombotic activity of SR 46349, a novel, potent and selective 5-HT2 receptor antagonist.
Herbert JM; Bernat A; Barthelemy G; Dol F; Rinaldi M
Thromb Haemost; 1993 Mar; 69(3):262-7. PubMed ID: 8470049
[TBL] [Abstract][Full Text] [Related]
14. [Platelet physiology. Advances in platelet reactivity. Review].
Vizcaíno-Salazar G
Invest Clin; 1994 Mar; 35(1):41-62. PubMed ID: 8054381
[TBL] [Abstract][Full Text] [Related]
15. Effects of the serotonin antagonists, cyproheptadine, ketanserin and mianserin, on cyclic flow reductions in stenosed canine coronary arteries.
Bush LR
J Pharmacol Exp Ther; 1987 Feb; 240(2):674-82. PubMed ID: 3806419
[TBL] [Abstract][Full Text] [Related]
16. Serotonin agonists and antagonists in experimental hypertension.
Saxena PR; Bolt GR; Dhasmana KM
J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S12-8. PubMed ID: 2446059
[TBL] [Abstract][Full Text] [Related]
17. Platelet serotonin-LDL interaction in essential hypertension.
Amstein R; Fetkovska N; Bühler FR
J Cardiovasc Pharmacol; 1991; 17 Suppl 5():S35-40. PubMed ID: 1717771
[TBL] [Abstract][Full Text] [Related]
18. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
[TBL] [Abstract][Full Text] [Related]
19. Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro.
Maayani S; Schwarz TE; Patel ND; Craddock-Royal BD; Tagliente TM
Platelets; 2003; 14(7-8):445-62. PubMed ID: 14713514
[TBL] [Abstract][Full Text] [Related]
20. 5HT2-receptors and serotonin release: their role in human platelet aggregation.
Cerrito F; Lazzaro MP; Gaudio E; Arminio P; Aloisi G
Life Sci; 1993; 53(3):209-15. PubMed ID: 8321084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
